top of page
Our Focus
Enabling earlier detection and improved monitoring of neurological disorders
Early detection of Alzheimer’s disease, Parkinson’s disease and other neurological disorders has substantial clinical benefits and can empower proactive treatment and care decisions.
The growing availability of medications developed to slow progression of these diseases increases the importance of accurate and timely diagnosis and monitoring for all patients. Unfortunately, currently available diagnostic tests are associated with significant limitations that may impede early diagnosis and monitoring of disease progression.
As an accurate, accessible and non-invasive technology, our APEX diagnostic platform offers the potential to provide earlier, more personalized diagnosis and treatment for individuals with these neurodegenerative diseases.
JOIN US
We are actively partnering with biopharma companies and researchers to validate the performance of the APEX diagnostic platform and bring it to market.
Interested in learning more about APEX?
bottom of page